Maeve O'Flynn

Partner

+44 (0)20 7864 2856 +44 (0)20 7864 2856
maeve.oflynn@finnegan.com maeve.oflynn@finnegan.com

1 London Bridge
London, United Kingdom SE1 9BG

vCard

Show Maeve's work in

Maeve O'Flynn is a European and UK patent attorney with more than a decade of in-house experience, having worked at some of the world's largest multinational corporations in the oil and chemical industries. She has worked for a range of clients, from startups to multinationals, covering diverse technologies such as cosmetics, sustainable chemistry, and catalysis. Intellectual Asset Management's Strategy 300 named Maeve as a Global Leader for 2023.

Maeve has helped clients develop commercially relevant intellectual property strategies. This includes developing and managing global patent portfolios, provisioning advice regarding trade secrets and defensive publications, and negotiating collaboration and licensing agreements.

Maeve has extensive experience preparing and prosecuting patent applications, from the initial invention harvesting sessions through to achieving allowance. She works with clients to assess and value their patent portfolios, and to develop filing strategies that support their commercial aims. She also represents clients at oral proceedings before the European Patent Office, representing both patentee and opponent.

Maeve has a first-class degree in chemistry from the University of Oxford, where she conducted surface chemistry research using scanning tunneling microscopy.

Et Cetera

Author. "The Importance of IP in the Chemical Industry," Chemical Industry Journal, 2018.
Co-author. "Direct Observation of behavior of Au nanoclusters on TiO2 (110) at elevated temperatures," Surface Science, 2001.

Experience

Comprehensive patent transactions and strategic counseling for one of the largest pharmaceutical companies in the world

Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.

Insights

Conference

Sustainable Fuels Global Summit Sustainable Fuels Global Summit

March 11-12, 2026

Rotterdam

Seminar

Voices From the Top: Insights from Women in IP and their Journey to Leadership Voices From the Top: Insights from Women in IP and their Journey to Leadership

November 25, 2025

London

European IP Blog

G 2/24: Don’t Be Late to the Party! G 2/24: Don’t Be Late to the Party!

3 October 2025

Webinar

Hot Topic: G 1/23 and the New “On-Sale Bar” at the EPO Hot Topic: G 1/23 and the New “On-Sale Bar” at the EPO

July 22, 2025

Webinar

European IP Blog

G 1/24 – A New Era of Claim Interpretation at the EPO? G 1/24 – A New Era of Claim Interpretation at the EPO?

27 June 2025

European IP Blog

Patent Statistics in the Cleantech Industry Patent Statistics in the Cleantech Industry

20 June 2025

Professional Recognition

"Maeve delivers professional and valuable advice. She is highly knowledgeable, well organized, helpful, always on time and prepared to work hard. Maeve is highly motivated to achieve success and is dedicated to her clients."